U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07053618) titled 'Interventional Left Ventricular Assist System for PCI in CHIP Patients' on June 23.
Brief Summary: Mechanical circulatory support (MCS) is a life-sustaining therapy first introduced in the 1950s. After six decades of development, it now serves as a critical bridge therapy for patients with acute cardiac events and end-stage heart failure. Percutaneous mechanical circulatory support (pMCS), a key MCS modality, has advanced rapidly in recent years.
In China, pMCS adoption has accelerated significantly, evidenced by year-over-year growth in both specialized centers and clinical cases, alongside continuous technological refinement.
Com...